What is Chengdu Easton Biopharmaceuticals Co Revenue per Share?
Chengdu Easton Biopharmaceuticals Co's revenue per share for the
three
months ended in Jun. 2024 was ¥1.99.
Chengdu Easton Biopharmaceuticals Co's revenue per share for the trailing twelve months (TTM) ended in Jun. 2024 was ¥6.99.
During the past 12 months, the average Revenue Per Share Growth Rate of Chengdu Easton Biopharmaceuticals Co was 21.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 0.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 0.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
SHSE:688513'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -2.7 Med: 10.2 Max: 39.3
Current: 0.4
During the past 8 years, Chengdu Easton Biopharmaceuticals Co's highest 3-Year average Revenue Per Share Growth Rate was 39.30% per year. The lowest was -2.70% per year. And the median was 10.20% per year.
SHSE:688513's 3-Year Revenue Growth Rate is ranked worse than 56.18% of 769
companies
in the Biotechnology industry
Industry Median: 3.7
vs SHSE:688513: 0.40
Chengdu Easton Biopharmaceuticals Co Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Chengdu Easton Biopharmaceuticals Co Revenue per Share Chart
Competitive Comparison of Chengdu Easton Biopharmaceuticals Co's Revenue per Share
For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chengdu Easton Biopharmaceuticals Co's PS Ratio Distribution in the Biotechnology Industry
* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's PS Ratio falls into.
Chengdu Easton Biopharmaceuticals Co Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Chengdu Easton Biopharmaceuticals Co Revenue per Share Related Terms
Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Chengdu Easton Biopharmaceuticals Co Business Description
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688513 has been successfully added to your 